TSC2 and macrophage activation syndrome: Supporting this hypothesis, the pathology of IL1rn deficiency and CpG-induced MAS was largely abrogated by rapamycin treatment while unrestricted activation of mTORC1 in Tsc2 KO mice was sufficient to elicit an SD-like syndrome, including both arthritis and fulminant MAS.